IQVIA (IQV) Stock Insights
IQV$274.62-4.42 -1.59%
$45.20B
Market Cap
32.64
P/E
21.22
Forward P/E
44
Score
IQVIA (IQV) Stock Insights
IQV price $274.62 -4.42 -1.59%
- Ticker
- IQV
- Price
- $274.62
- Change
- -4.42 -1.59%
- Market cap ?
- $45.20B
- P/E ?
- 32.64
- Forward P/E ?
- 21.22
- Dividend yield ?
- 0.00%
- Beta ?
- 1.17
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- Stocklytics score
- 44
- Value
- 40
- Quality
- 34
- Growth
- 57
Stocklytics score rationale: value 40, quality 34, growth 57.
Financials
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| 6815000000 | 9702000000 | 10412000000 | 11088000000 | 11359000000 | 13874000000 | 14410000000 | 14984000000 | 15405000000 | 16310000000 |
IQVIA Holdings Inc. is a premier global provider of sophisticated analytical insights, advanced technology solutions, and comprehensive clinical research services, catering to the life sciences industry across the Americas, Europe, Africa, and Asia-Pacific. The company's operations are structured into three key divisions: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales &…
Insights
- Revenue by product
- Revenue by region
| Period | Value |
|---|---|
| FY2013 | Healthcare Services: 888610000.0, Product Development: 2919730000.0 |
| FY2014 | Healthcare Services: 1067991000.0, Product Development: 3097831000.0 |
| FY2015 | Healthcare Services: 1134789000.0, Product Development: 3191630000.0 |
| FY2016 | Research And Development Solutions: 3472000000.0 |
| FY2017 | Research And Development Solutions: 3647000000.0 |
| FY2018 | Contract Sales And Medical Solutions: 235000000.0, Research And Development Solutions: 1693000000.0, Technology And Analytics Solutions: 1520000000.0 |
| FY2019 | Contract Sales And Medical Solutions: 200000000.0, Research And Development Solutions: 1734000000.0, Technology And Analytics Solutions: 1543000000.0 |
| FY2020 | Contract Sales And Medical Solutions: 741000000.0, Research And Development Solutions: 5760000000.0, Technology And Analytics Solutions: 4858000000.0 |
| FY2021 | Contract Sales And Medical Solutions: 784000000.0, Research And Development Solutions: 7556000000.0, Technology And Analytics Solutions: 5534000000.0 |
| FY2022 | Contract Sales And Medical Solutions: 743000000.0, Research And Development Solutions: 7921000000.0, Technology And Analytics Solutions: 5746000000.0 |
| FY2023 | Contract Sales And Medical Solutions: 727000000.0, Research And Development Solutions: 8395000000.0, Technology And Analytics Solutions: 5862000000.0 |
| FY2024 | Contract Sales And Medical Solutions: 718000000.0, Research And Development Solutions: 8527000000.0, Technology And Analytics Solutions: 6160000000.0 |
| FY2025 | Contract Sales And Medical Solutions: 788000000.0, Research And Development Solutions: 8896000000.0, Technology And Analytics Solutions: 6626000000.0 |
| Period | Value |
|---|---|
| FY2013 | Americas: 1532974000.0, Asia Pacific: 773862000.0, Europe And Africa: 1501504000.0 |
| FY2014 | Americas: 1783999000.0, Asia Pacific: 858285000.0, Europe And Africa: 1523538000.0 |
| FY2015 | Americas: 1973501000.0, Asia Pacific: 892928000.0, E M E A: 1459990000.0 |
| FY2016 | Americas: 2378000000.0, Asia Pacific: 931000000.0, EMEA: 2055000000.0 |
| FY2017 | Americas: 3607000000.0, Asia Pacific: 1335000000.0, E M E A: 3118000000.0 |
| FY2023 | Americas: 7552000000.0, Asia Pacific: 2973000000.0, EMEA: 4459000000.0 |
| FY2024 | Americas: 7356000000.0, Asia Pacific: 3129000000.0, EMEA: 4920000000.0 |
| FY2025 | Americas: 7745000000.0, Asia Pacific: 3380000000.0, EMEA: 5185000000.0 |
Insights · Dividends · Forecast · Financials · Learn